Efstathios N Stathopoulos Selected Research

Efstathios N Stathopoulos Research Topics

Disease

25	Neoplasms (Cancer) 01/2020 - 09/2002
12	Breast Neoplasms (Breast Cancer) 01/2020 - 07/2005
6	Prostatic Neoplasms (Prostate Cancer) 04/2013 - 09/2002
5	Carcinoma (Carcinomatosis) 01/2012 - 01/2003
4	Multiple Myeloma 01/2020 - 10/2006
3	Neoplasm Metastasis (Metastasis) 01/2019 - 09/2010
3	Merkel Cell Carcinoma 04/2011 - 07/2008
3	Hyperplasia 04/2008 - 01/2003
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2019 - 08/2007
2	Inflammation (Inflammations) 01/2013 - 02/2012
2	Triple Negative Breast Neoplasms 08/2012 - 02/2011
2	Circulating Neoplastic Cells 05/2009 - 11/2007
2	Hypoxia (Hypoxemia) 01/2009 - 10/2007
2	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 01/2005 - 11/2004
1	Melanoma (Melanoma, Malignant) 09/2017
1	Lung Injury 01/2014
1	Malignant Mesothelioma 07/2013
1	Mesothelioma 07/2013
1	Carcinogenesis 04/2013
1	Lung Neoplasms (Lung Cancer) 04/2013
1	Glioma (Gliomas) 01/2013
1	Hepatocellular Carcinoma (Hepatoma) 11/2012
1	Urinary Bladder Neoplasms (Bladder Cancer) 08/2012
1	Colitis 06/2012
1	Septic Shock (Toxic Shock Syndrome) 06/2012
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 02/2012
1	Psoriasis (Pustulosis Palmaris et Plantaris) 02/2012
1	Burns 02/2011
1	Stevens-Johnson Syndrome (Lyell's Syndrome) 02/2011
1	Blister (Bulla) 02/2011
1	Eosinophilic pustular folliculitis 02/2011
1	Renal Cell Carcinoma (Grawitz Tumor) 01/2011
1	Endometrial Hyperplasia 12/2010
1	Lymphoma (Lymphomas) 01/2009
1	Hodgkin Disease (Hodgkin's Disease) 01/2009
1	Noninfiltrating Intraductal Carcinoma (DCIS) 04/2008

Drug/Important Bio-Agent (IBA)

8	LigandsIBA 01/2020 - 03/2008
7	Androgen Receptors (Androgen Receptor)IBA 01/2019 - 02/2005
7	Proteins (Proteins, Gene)FDA Link 01/2014 - 02/2005
7	Testosterone (Sustanon)FDA Link 04/2011 - 09/2002
5	AndrogensIBA 01/2019 - 01/2003
4	bis(3- bis(4- chlorophenyl)methyl- 4- dimethylaminophenyl)amineIBA 01/2020 - 02/2012
4	CytokinesIBA 01/2014 - 03/2008
4	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 08/2012 - 04/2008
3	Estrogen ReceptorsIBA 01/2019 - 10/2007
3	Estrogen Receptor alphaIBA 01/2019 - 02/2011
3	MicroRNAs (MicroRNA)IBA 01/2014 - 02/2011
3	Biological ProductsIBA 02/2013 - 07/2008
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2020 - 03/2008
2	Phosphotransferases (Kinase)IBA 01/2019 - 04/2013
2	Transcription Factors (Transcription Factor)IBA 02/2013 - 08/2012
2	angiogeninIBA 09/2012 - 01/2005
2	Interleukin-6 (Interleukin 6)IBA 09/2012 - 11/2004
2	Progesterone Receptors (Progesterone Receptor)IBA 08/2012 - 10/2007
2	Stem Cell FactorIBA 04/2011 - 01/2009
2	InterferonsIBA 02/2011 - 07/2008
2	Keratin-19 (Keratin 19)IBA 05/2009 - 11/2007
2	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 05/2009 - 11/2007
2	Messenger RNA (mRNA)IBA 05/2009 - 11/2007
2	SteroidsIBA 10/2007 - 07/2005
2	ParaffinIBA 08/2007 - 11/2005
1	Protein Isoforms (Isoforms)IBA 01/2019
1	EpitopesIBA 01/2019
1	AntibodiesIBA 01/2019
1	Protein Kinase CIBA 09/2017
1	AcidsIBA 01/2014
1	Hydrochloric Acid (Hydrogen Chloride)FDA Link 01/2014
1	AsbestosIBA 07/2013
1	Interleukin-8 (Interleukin 8)IBA 07/2013
1	Urethane (Ethyl Carbamate)IBA 04/2013
1	Phenobarbital (Luminal)FDA Link 02/2013
1	Cyclin D1IBA 02/2013
1	ElementsIBA 02/2013
1	Fibroblast Growth Factor 2 (Basic Fibroblast Growth Factor)IBA 09/2012
1	platelet-derived growth factor ABIBA 09/2012
1	RNA (Ribonucleic Acid)IBA 08/2012
1	Dextran SulfateIBA 06/2012
1	Nitric Oxide Synthase Type III (Endothelial Nitric Oxide Synthase)IBA 01/2012
1	Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA 01/2012
1	Hormones (Hormone)IBA 04/2011
1	taxaneIBA 04/2011
1	proanthocyanidinIBA 04/2011
1	Proanthocyanidins (Procyanidins)IBA 04/2011
1	Peptides (Polypeptides)IBA 02/2011
1	perforin-granzyme BIBA 02/2011
1	antalarminIBA 09/2010
1	CateninsIBA 09/2010
1	B-Cell Activating FactorIBA 11/2009
1	Caspase 3 (Caspase-3)IBA 01/2009
1	Platelet-Derived Growth Factor Receptors (Platelet-Derived Growth Factor Receptor)IBA 01/2009
1	Platelet-Derived Growth Factor alpha ReceptorIBA 01/2009
1	Interferon-alpha (Interferon Alfa)IBA 07/2008

Therapy/Procedure

3	Drug Therapy (Chemotherapy) 01/2011 - 09/2002
2	Therapeutics 02/2013 - 04/2011
2	Adjuvant Chemotherapy 05/2009 - 11/2007
1	Biological Therapy 01/2020
1	Castration 04/2013
1	Immunotherapy 01/2011
1	Curettage 12/2010
1	Hysterectomy 12/2010